Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06287944
What this trial is testing

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 15
Early research (Phase 1)Study completedNCT00550784
What this trial is testing

Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
City of Hope Medical Center 8
Testing effectiveness (Phase 2)UnknownNCT01178658
What this trial is testing

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Seoul National University Hospital 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT00716066
What this trial is testing

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Who this might be right for
Autoimmune DiseaseNeurologic Autoimmune DiseaseAutologous Transplant Autoimmune+16 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Ended earlyNCT00121186
What this trial is testing

S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07085156
What this trial is testing

Reduced Intensity Conditioning for MDS

Who this might be right for
MDS
Ruijin Hospital 45
Early research (Phase 1)Study completedNCT00565968
What this trial is testing

Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg

Who this might be right for
Melanoma (Skin)
Duke University 20
Not applicableStudy completedNCT02716103
What this trial is testing

Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT05436561
What this trial is testing

Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies

Who this might be right for
Disease-free Survival
Shanghai Jiao Tong University School of Medicine 61
Testing effectiveness (Phase 2)UnknownNCT00382694
What this trial is testing

Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Nordic Myeloma Study Group 80
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Study completedNCT00925782
What this trial is testing

PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation

Who this might be right for
Multiple Myeloma
Acrotech Biopharma Inc. 24
Not applicableStudy completedNCT00856388
What this trial is testing

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more
Roswell Park Cancer Institute 62
Large-scale testing (Phase 3)Looking for participantsNCT07396480
What this trial is testing

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial

Who this might be right for
VenentoclaxMyeloid MalignanciesConditioning+3 more
First Affiliated Hospital of Zhejiang University 186
Post-approval studies (Phase 4)Active Not RecruitingNCT03829371
What this trial is testing

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

Who this might be right for
Multiple Myeloma
University of Turin, Italy 450
Testing effectiveness (Phase 2)Study completedNCT01190787
What this trial is testing

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 150
Large-scale testing (Phase 3)Study completedNCT00950768
What this trial is testing

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple MyelomaDiagnosis
Azienda Ospedaliera San Giovanni Battista 298
Large-scale testing (Phase 3)Study completedNCT00001296
What this trial is testing

Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 122
Testing effectiveness (Phase 2)Study completedNCT03346096
What this trial is testing

TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma

Who this might be right for
Malignant Lymphoma
Sheba Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT00004250
What this trial is testing

Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)Sarcoma
Memorial Sloan Kettering Cancer Center 35
Next Page